Investors

FoldRx is backed financially by top-tier venture capital firms. The company has raised $59 million to date, including $43 million in May 2006 in a Series B funding round led by Texas Pacific Group Ventures and Alta Partners, and including Novartis BioVenture Fund, HealthCare Ventures, and Fidelity Biosciences.